Inhibition of Chlamydia pneumoniae growth in HEp-2 cells pretreated with gamma interferon and tumor necrosis factor alpha.
AUTOR(ES)
Summersgill, J T
RESUMO
An in vitro culture system was used to study the effects of increasing concentrations of human cytokines on the intracellular replication of Chlamydia pneumoniae. HEp-2 cell monolayers, pretreated for 24 h with 200 U of human recombinant gamma interferon (IFN-gamma) per ml restricted the intracellular replication of C. pneumoniae. Tumor necrosis factor alpha (TNF-alpha; 25 ng/ml) exhibited a synergistic effect with IFN-gamma by reducing the concentration of IFN-gamma necessary to restrict intracellular growth to 100 U/ml. The addition of 200 micrograms of tryptophan per ml significantly reversed the inhibitory effects of IFN-gamma and TNF-alpha, suggesting involvement of the indoleamine-2,3-dioxygenase pathway in the restriction process.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=173379Documentos Relacionados
- Characterization of Chlamydia pneumoniae Persistence in HEp-2 Cells Treated with Gamma Interferon
- Lymphotoxin Inhibits Chlamydia pneumoniae Growth in HEp-2 Cells
- Association between virulence of Yersinia pestis and suppression of gamma interferon and tumor necrosis factor alpha.
- Involvement of Nicotinic Acetylcholine Receptors in Controlling Chlamydia pneumoniae Growth in Epithelial HEp-2 Cells
- Inhibition of Rickettsia conorii growth by recombinant tumor necrosis factor alpha: enhancement of inhibition by gamma interferon.